Business Standard

Sunday, December 22, 2024 | 07:20 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

After Gambia, now Uzbekistan alleges Indian cold drug killed its children

Noida-based Marion Biotech's Dok-1 Max anti-cold medicine under scanner after the Central Asian nation blames it for 18 deaths

cough syrup, medicine, cold
Premium

File photo of cough syrup | Photo: Shutterstock

Sohini Das Mumbai
After Gambia, it is now Uzbekistan that has alleged that children in that country have died after consuming medicines manufactured by an Indian drug firm.

The Union Health Ministry did not immediately respond to queries.

According to reports by an Uzbek news website AKI.com, anti-cold medicine brand Dok-1 Max, manufactured by Noida-based Marion Biotech, is allegedly behind the deaths of as many as 18 children. Uzbekistan's Health Ministry has said that samples of Dok-1 Max contained ethylene glycol. Dok-1 Max syrup and tablets are used as anti-cold medication.

Ethylene Glycol is a toxic substance found in industrial grade glycerine, and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in